A Crohn's disease-associated gene expression profile and microbial community

July 8, 2014

Crohn's and other inflammatory bowel diseases (IBDs) can be painful and debilitating. There are no known cures for these diseases, but the symptoms can be managed. It is widely thought that IBDs develop as a result of an individual's genetic make-up, their gut microbiota, and environmental cues, though it is not fully understood how these factors promote IBDs.

A new study in the Journal of Clinical Investigation identifies a specific gene expression profile and microbial community associated with Crohn's disease. Lee Denson and colleagues at Cincinnati Children's Hospital Medical Center compared the intestines of healthy patients to pediatric Crohn's disease patients.

Crohn's disease patients had altered expression of 2 genes, DUOX2 and APOA1, as well as a distinct microbial community. Furthermore, APOA1 expression and microbial abundance could be used to predict clinical outcomes in Crohn's disease patients.

Explore further: Newly diagnosed Crohn's disease patients show imbalance in intestinal microbial population

More information: Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature, J Clin Invest. DOI: 10.1172/JCI75436

Related Stories

Specific bacterial species may initiate, maintain Crohn's

October 22, 2012

Patients newly diagnosed with pediatric Crohn's disease had significantly different levels of certain types of bacteria in their intestinal tracts than age-matched controls, according to a paper in the October Journal of ...

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.